Jonathan Moss (J G Moss)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Early Breast Cancer

Health Promotion

Top Venues

Health technology assessment (Winchester, England)

CVIR endovascular

Circulation. Cardiovascular interventions

This page only lists publications with an associated author ORCID identifier.

Publications

Hannah O'Keeffe, Darren Green, Áine M de Bhailis, Rajkumar Chinnadurai, Keith Wheatley, Jonathan Moss, Philip A Kalra, null null
Long Term Outcomes After Renal Revascularization for Atherosclerotic Renovascular Disease in the ASTRAL Trial. Circulation. Cardiovascular interventions (2024)
Jane P Daniels, Lee J Middleton, Versha Cheed, William McKinnon, Dikshyanta Rana, R Fusun Sirkeci, Isaac Manyonda, Anna-Maria Belli, Mary-Ann Lumsden, Jonathan Moss, Olivia Wu, Klim McPherson
Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT. Health technology assessment (Winchester, England) 26 (22) (2022)
Olivia Wu, Elaine McCartney, Robert Heggie, Evi Germeni, James Paul, Eileen Soulis, Susan Dillon, Caoimhe Ryan, Moira Sim, Judith Dixon-Hughes, Roshan Agarwal, Andrew Bodenham, Tobias Menne, Brian Jones, Jonathan Moss
Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT. Health technology assessment (Winchester, England) 25 (47) (2021)
R Yadavali, G Ananthakrishnan, M Sim, K Monaghan, G McNaught, I Hamoodi, F Bryden, S Lassman, Jonathan Moss
Randomised trial of two embolic agents for uterine artery embolisation for fibroids: Gelfoam versus Embospheres (RAGE trial). CVIR endovascular 2 (1) (2019)